EyeCyte Alternatives & Competitors
12 companies similar to EyeCyte — Partnering with esteemed institutions to pioneer new treatments for retinal dise...
Companies similar to EyeCyte
Cognition Therapeutics, Inc.
Advancing Accessible Solutions for Complex Neurodegenerative Diseases
Neurotrope Inc.
Developing a new approach to combating Alzheimer's disease and other neurodegenerative dis...
Anthera Pharmaceuticals
Pioneering Therapeutics to Combat Inflammatory Diseases, Pioneering Better Health
Spinogenix, Inc.
Developing a new class of therapeutics for neurodegenerative and psychiatric diseases
Rival Readout
Competing with EyeCyte? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Amyl Therapeutics
Restoring clarity in amyloid diseases
ProteoTech
Advancing Therapeutics and Diagnostics for Amyloid Diseases Since 1996
Creative BioTherapeutics LLC
An emerging biotech discovering & developing novel therapies for cancer and viruses where...
Drive Therapeutics
Addressing Unmet Needs in Retinal Therapeutics
AsclepiX Therapeutics
Fraud Alert Regarding Third Party Employment Agencies
GENFIT
Dedicated to improving the lives of patients with liver diseases characterized by high unm...
SparingVision
Genomic Medicines For Ocular Diseases
Handl Therapeutics
Handl Therapeutics develops gene therapies for complex neurodegenerative diseases through...
About EyeCyte
EyeCyte is a biotechnology firm that partners with elite institutions like Pfizer's Bioinnovation and io therapeutics Center and The Scripps Research Institute to develop innovative treatments for retinal diseases. Since its inception in 2005, EyeCyte has maintained its focus on addressing neovascular and degenerative...
Retinal Diseases, Therapeutics, Research, Partnerships, Innovation, Ophthalmology, Drug Development, Pfizer, Bioinnovation, Scripps Research Institute, Neovascular Disease, Degenerative Disease, Medical Collaboration, Clinical Trials
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around EyeCyte: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at EyeCyte on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.